Beranda › Gangguan Darah
Uji klinis Gangguan Darah yang merekrut di AS
33 studi untuk Gangguan Darah merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Atlanta, GA10 studi
- Boston, MA10 studi
- Los Angeles, CA9 studi
- Houston, TX9 studi
- The Bronx, NY8 studi
- Nashville, TN7 studi
- New York City, NY7 studi
- Mountain View, CA6 studi
- Seattle, WA5 studi
- Washington, DC5 studi
- Durham, NC5 studi
- Greenville, NC5 studi
- Portland, OR5 studi
- Tampa, FL4 studi
- Milwaukee, WI4 studi
- Philadelphia, PA4 studi
- San Diego, CA4 studi
- Birmingham, AL4 studi
- Baltimore, MD3 studi
- Kansas City, MO3 studi
- Columbus, OH3 studi
- Norfolk, VA3 studi
- Phoenix, AZ3 studi
- Miami, FL3 studi
- Cedar Rapids, IA3 studi
- Buffalo, NY3 studi
- Indianapolis, IN3 studi
- Cleveland, OH3 studi
- Baldwin Park, CA3 studi
- Clifton, NJ3 studi
- Louisville, KY3 studi
Berdasarkan negara bagian
- Alabama5 studi
- Arizona3 studi
- Arkansas3 studi
- California16 studi
- Distrik Columbia4 studi
- Florida9 studi
- Georgia11 studi
- Indiana3 studi
- Iowa3 studi
- Kentucky4 studi
- Maryland5 studi
- Massachusetts10 studi
- Minnesota3 studi
- Missouri4 studi
- New Jersey5 studi
- New York12 studi
- North Carolina9 studi
- Ohio6 studi
- Oregon5 studi
- Pennsylvania4 studi
- Tennessee7 studi
- Texas10 studi
- Virginia5 studi
- Washington6 studi
- Wisconsin4 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Menerima pesertaFase 3
Usia 12 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06439082Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06910969Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Menerima pesertaFase 3
Usia 18 hingga 71 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07504458Treatment of Hemophilia A Patients With FVIII Inhibitors
Menerima pesertaStudi observasional
Semua usia · Pria · Diperbarui 23 Sep 2026 · NCT04023019A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06722235(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT04996875A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07059000A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06948318Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT07601425A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07075185ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04398628A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT05254743Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07216443Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
Menerima peserta
Hingga usia 55 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01666080Therapeutic RSK1 Targeting in Myelofibrosis
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT07379125A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Apr 2026 · NCT04256317ATHNdataset Registry
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 21 Apr 2026 · NCT06820515Diamond Blackfan Anemia Registry (DBAR)
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT00106015Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT06828796Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 19 ke atas · Semua jenis kelamin · Diperbarui 2 Apr 2026 · NCT03207854Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
Menerima pesertaFase 3
Usia 12 hingga 35 · Semua jenis kelamin · Diperbarui 23 Mar 2026 · NCT05477563Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback
Menerima pesertaFase 1
1 Month – 45 Years · Semua jenis kelamin · Diperbarui 8 Jan 2026 · NCT04640987Hematology Biobank: In Vitro Study of Blood Disorders
Menerima pesertaStudi observasional
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 6 Jan 2026 · NCT02442011CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL
Menerima pesertaFase 1
3 Months – 30 Years · Semua jenis kelamin · Diperbarui 28 Nov 2025 · NCT06559189BMT-CARE: Psychosocial Intervention for Transplant Caregivers
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Okt 2025 · NCT06472089Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.